Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Biotech

Novartis’ Lp(a) wipeout casts shadow over Amgen, Lilly programs

Novartis reported a total absence of efficacy that could intensify questions about upcoming readouts from Amgen and Eli Lilly.

Nick Paul Taylor Nov 7, 2026 9:50am

Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

Novo saying goodbye to longtime finance chief—Chutes & Ladders

Nov 6, 2026 10:12am

How AI is reshaping biopharma decision-making

Brought to you by Clarivate

Dark blue background with stylized DNA strands and data particles evoking a scientific or biotech theme The text reads T

There's more than one way to build a biotech

Nov 6, 2026 10:02am

Biotech value creation at an inflection point

Brought to you by Lumanity

Generate sees ‘huge opportunity’ using Claude to improve CAR-Ts

Nov 6, 2026 10:02am